Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: A case of "pseudocirrhosis"

Digestive Diseases and Sciences

Volumn 52, Issue 3, 2007, Pages 749-752

  Sass, David A ^a,b   Clark, Kenneth ^a   Grzybicki, Dana ^a   Rabinovitz, Mordechai ^a   Shaw Stiffel, Thomas A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

"Pseudocirrhosis"; Desmoplastic metastatic breast cancer; FDG PET; Portal hypertension; Tamoxifen

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; TAMOXIFEN;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER CIRRHOSIS; LIVER METASTASIS; MASTECTOMY; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FATAL OUTCOME; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; TAMOXIFEN;

EID: 33847229129     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9332-9     Document Type: Article

References (12)

1. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR 163:1385-1388
2. Nascimento AB, Mitchell DG, Rubin R, Weaver E (2001) Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology 221:117-121
3. Shirkhoda A, Baird S (1994) Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging 19:39-42
4. Fennessy FM, Mortele KJ, Kluckert T, Gogate A, Ondategui-Parra S, Ros P, Silverman SG (2004) Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR 182:651-655
5. Moon DH, Maddahi J, Silverman DHS, Glaspy JA, Phelps ME, Hoh CK (1998) Accuracy of whole-body Fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39:431-435
6. 18FDG to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18:1676-1688
7. 18FDG for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18:1689-1695
8. Loomus GN, Aneja P, Bota RA (1983) A case of peliosis hepatic in association with tamoxifen therapy. AmJ Clin Pathol 80:881-883
9. Moffat DF, Oien KA, Dickson J, et al. (2000) Hepatocellular carcinoma after long-term tamoxifen therapy. Ann Oncol 11:1195-1196
10. Pinto HC, Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC (1995) Tamoxifen-associated steatohepatitis - report of three cases. J Hepatol 23:95-97
11. Storen EC, Hay JE, Kaur J, et al. (2000) Tamoxifen-induced submassive hepatic necrosis. Cancer J 6:58-60
12. Oien KA, Moffat DF, Curry GW, Dickson J, Habeshaw T, Mills PR, MacSween RNM (1999) Cirrhosis with staetohepatitis after adjuvant tamoxifen. Lancet 353:36-37